AMO's IOL to be reimbursed in US
Following designation of New Technology Intraocular Lens (NTIOL) status by the Centers for Medicare and Medicaid Services (CMS), AMO has introduced the Tecnis 1-Piece IOL to the US market.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Recent Videos
Related Content
